Sun Pharma Q3 profit up 5% at ₹2,166 crore; stock closes 2% lower
Sun Pharma to acquire US-based Concert for $576 million
Jefferies says big pharma firms to get bigger; lists Sun Pharma and Syngene as top picks, downgrades Biocon, Cipla